NCT00534417 2013-02-01Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast CancerAccelerated Community Oncology Research NetworkPhase 2 Completed41 enrolled 13 charts